Document is current
Any future updates will be listed below
-
Authors
Zhang, Xuedi
Sun, Yue
Xie, Minyao
Song, Shasha
Zhang, Huan
Zhou, Ping
Zhang, Ning
Liu, Na
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China Youth Program (81901390)
Jiangsu Provincial Key Research and Development Program (BE2021616)
Jiangsu Provincial Social Development Project - General Program (BE2022678)
Nanjing Municipal Health Commission Key Research Project (ZKX20029)
- License Information
-
More Information
Article History
Received: 21 April 2025
Accepted: 9 July 2025
First Online: 8 August 2025
Declarations
:
: The study received approval from the Ethics Committee of the Affiliated Brain Hospital of Nanjing Medical University (IRB No. 2020-KY208-01). This study was conducted in strict accordance with: 1. ICH-GCP (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice). 2. World Medical Association Declaration of Helsinki (2013 revision). 3. Relevant Chinese regulations and laws. 3. Relevant Chinese regulations and laws. Written informed consent was obtained from all participants. For individuals under 16 years of age, consent was provided by legally authorised guardians.
: Not applicable (No individual personal data presented).
: The authors declare no competing interests.
